Literature DB >> 26653629

Making Sense of Statistics in Clinical Trial Reports: Part 1 of a 4-Part Series on Statistics for Clinical Trials.

Stuart J Pocock1, John J V McMurray2, Tim J Collier3.   

Abstract

This paper is a practical guide to the essentials of statistical analysis and reporting of randomized clinical trials (RCTs). It is the first in a series of 4 educational papers on statistical issues for RCTs, which will also include statistical controversies in RCT reporting and interpretation, the fundamentals of design for RCTs, and statistical challenges in the design and monitoring of RCTs. Here, we concentrate on displaying results in tables and figures, estimating treatment effects, expressing uncertainty using confidence intervals, and using p values wisely to assess the strength of evidence for a treatment difference. The various methods and their interpretation are illustrated by recent, topical cardiology trial results.
Copyright © 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Keywords:  clinical trials; interpretation; publication; statistics

Mesh:

Year:  2015        PMID: 26653629     DOI: 10.1016/j.jacc.2015.10.014

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  8 in total

1.  SECURE PCI: how important can a subgroup analysis be?

Authors:  Mathieu Kerneis; Megan K Yee; C Michael Gibson
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

2.  Optimum dose of vitamin D for disease prevention in older people: BEST-D trial of vitamin D in primary care.

Authors:  H Hin; J Tomson; C Newman; R Kurien; M Lay; J Cox; J Sayer; M Hill; J Emberson; J Armitage; R Clarke
Journal:  Osteoporos Int       Date:  2016-12-16       Impact factor: 4.507

Review 3.  Critical appraisal of cardiology guidelines on revascularisation: clinical practice.

Authors:  David R Dobies; Kimberly R Barber
Journal:  Open Heart       Date:  2018-02-24

4.  Transthoracic versus intra-operative transesophageal echocardiography in right heart assessment.

Authors:  Saberio Lo Presti; Daniela Urina; Tarec K Elajami; Ivan A Arenas; Steve Xydas; Francesco Nappi; Ana V Soto; Esteban Escolar; Christos G Mihos
Journal:  J Thorac Dis       Date:  2020-05       Impact factor: 2.895

Review 5.  Sacubitril/Valsartan in Asian Patients with Heart Failure with Reduced Ejection Fraction.

Authors:  Pooja Dewan; Kieran F Docherty; John J V McMurray
Journal:  Korean Circ J       Date:  2019-06       Impact factor: 3.243

6.  The Medical Information Scientific Process: Define, Research, Evaluate, Synthesize, and Share (DRESS).

Authors:  Dominick Albano; Farah Pragga; Rena Rai; Teresa Flowers; Prachi Parmar; Susan Wnorowski; Evelyn R Hermes-DeSantis
Journal:  Ther Innov Regul Sci       Date:  2022-03-03       Impact factor: 1.778

Review 7.  Phase III Clinical Trials in First-Line Follicular Lymphoma: A Review of Their Design and Interpretation.

Authors:  Emmanuel Bachy; Kaspar Rufibach; Joana Parreira; Aino Launonen; Tina Nielsen; Allan Hackshaw
Journal:  Adv Ther       Date:  2021-05-26       Impact factor: 3.845

Review 8.  The neprilysin pathway in heart failure: a review and guide on the use of sacubitril/valsartan.

Authors:  Pardeep S Jhund; John J V McMurray
Journal:  Heart       Date:  2016-05-20       Impact factor: 5.994

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.